Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular biomolecules (damaged by Protoporphyrin IX-generated reactive oxygen species) refers to the collective group of intracellular constituents, including membrane lipids, structural proteins, and nucleic acids, that serve as the functional targets of photodynamic therapy (PDT). This therapeutic approach relies on the accumulation of the photosensitizer Protoporphyrin IX (PpIX) within target cells, often achieved by administering the precursor 5-aminolevulinic acid (ALA) (Wachowska et al., 2011). Upon exposure to specific wavelengths of light, PpIX enters an excited state and transfers energy to molecular oxygen, generating highly reactive oxygen species (ROS), predominantly singlet oxygen (Agostinis et al., 2011). These ROS cause immediate and localized oxidative damage to organelles where PpIX is concentrated, such as the mitochondria, lysosomes, and endoplasmic reticulum (Krammer, 2001). The resulting destruction of vital biomolecules disrupts cellular integrity and signaling, ultimately triggering cell death through apoptosis, necrosis, or autophagy. This mechanism is widely utilized in the clinical treatment of various malignancies and dermatological conditions like actinic keratosis. Because the damage is confined to the area of light illumination and photosensitizer accumulation, it offers a degree of selectivity for diseased tissue.
Generation of reactive oxygen species (ROS), primarily singlet oxygen, upon light activation of Protoporphyrin IX, leading to oxidative damage of lipids, proteins, and DNA, ultimately causing cell death.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular biomolecules (damaged by Protoporphyrin IX-generated reactive oxygen species).